Bad Hofgastein, 28 September 2016.
The European Antibiotic Awareness Day (EAAD), launched by the European Centre for Disease Prevention and Control (ECDC) has been awarded the prestigious European Health Award (EHA) of €10,000 at the European Health Forum Gastein (EHFG) 2016. The initiative raises awareness about the threat to public health of antimicrobial resistance and the importance of prudent antibiotic use.
For the past decade, the International Forum Gastein (IFG) has presented the EHA in recognition of transnational projects that contribute to improving public health and healthcare systems in Europe. Helmut Brand, President of the IFG explains that “the award supports initiatives focused on the development of sustainable and innovative concepts, which successfully address current challenges such as disparities in health status and access to healthcare as well as improvements in medical care and treatment options.”
The EHA jury, made up of high-ranking European health experts, selected the EAAD for its impact and sustainability. The jury stated: “The project is dealing with probably the most important threat to public health today: antimicrobial resistance (AMR). The EAAD has contributed to placing this issue high on the national and international public and political agenda”.
Dr. Pamela Rendi-Wagner, Head of Public Health Section, Austrian Federal Ministry of Health and Women’s Affairs (BMGF) said “Antibiotics are indispensable therapeutics for the treatment of infectious diseases. However, a prudent use of antibiotics is essential in order to prevent AMR. It is fundamental to raise awareness about rational use and hospital hygiene. Therefore, we see it as an important sign to award EAAD with the EHA”.
The goal of EAAD is to provide the participating countries with evidence-based tools, as well as technical and political support for their campaigns. In accepting the award, Dr. Andrea Ammon, Acting Director of the EAAD said: “This award recognises the value the European Antibiotic Awareness Day has in raising prudent antibiotic use and resistance as priorities for governments and health authorities across the European Union and beyond.”